header-langage
简体中文
繁體中文
English
Tiếng Việt
한국어
日本語
ภาษาไทย
Türkçe
Scan to Download the APP
Partnered With:

Biotechnology company Eyenovia launches HYPE treasury reserve strategy, planning to invest $50 million

BlockBeats News, June 18, according to market reports, clinical-stage ophthalmic biopharmaceutical company Eyenovia announced an investment of $50 million to launch the Hyperliquid (HYPE) treasury reserve strategy.

举报 Correction/Report
RelatedRecommended
Interview Eyenovia Executive: How to Utilize HYPE to Embrace the Crypto Stock Frenzy Narrative?
US Biotech Company Transforms into a DeFi Project, an Experiment in Capital Rebirth Fueled by HYPE.
When HYPE Becomes Market Consensus, Where Does the Buying Pressure Come From?
Arthur Hayes' price target for HYPE in August 2026 is $150.
Correction/Report
Submit
Add Library
Visible to myself only
Public
Save
Choose Library
Add Library
Cancel
Finish